About NeuShen Therapeutics
We are a global biotech company committed to developing new and effective therapies for psychiatric and neurological disorders affecting millions of patients in need.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Shanghai, China
Team Size
11-50
Tracked Since
Oct 9, 2026
Web & Domain Identity
Official Website
neushen.com
Domain Registered Date
Jun 7, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $80,000,000 · Series-B
Backed by B Capital, Legend Capital
- Capital Raise
Raised $20,000,000 · Seed
Backed by Lapam Capital, BioVenture
- Milestone
Website domain registered
neushen.com
Investors & Backers
B Capital
BioVenture
Lapam Capital
Legend Capital
Lilly Asia Ventures
Matrix Partners China
Pivotal bioVenture Partners
Qiji Investment
Shanghai Guotou Pioneer
TruMed Investment
Funding History
Series-B equity
· Sep 7, 2026
Round backers: B Capital, Legend Capital, Lilly Asia Ventures, Matrix Partners China, Shanghai Guotou Pioneer, TruMed Investment
$80,000,000 thepharmaletter.com
Seed equity
· Sep 29, 2022
Round backers: Lapam Capital, BioVenture
$20,000,000 prnewswire.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026